Laboratory tests in primary care · by Dr Solange Déplanque and Dr Michaël Rochoy

Itching in pregnancy (intrahepatic cholestasis of pregnancy)

Gynaecology and obstetrics · Symptom or situation · updated 2026-10-30

BioMG follows French guidelines. Adapt it to the guidelines and the tests available where you practise.

Frequency: About 1% of pregnancies worldwide, from 0.1 to 2% depending on the country [1]

Itching in pregnancy: look for intrahepatic cholestasis of pregnancy

Fasting sample.

Fasting laboratory tests

Detailed explanation and international comparison (in French): read it in English (machine translation)

Do not order

Confirmed intrahepatic cholestasis of pregnancy: monitoring

Fasting sample.

At the frequency set with the maternity unit

Detailed explanation and international comparison (in French): read it in English (machine translation)

After delivery

8 to 12 weeks after delivery

Detailed explanation and international comparison (in French): read it in English (machine translation)

Sources (11)
  1. Sentilhes L, Sénat MV, Bouchghoul H, et al. La cholestase gravidique : recommandations pour la pratique clinique du Collège national des gynécologues obstétriciens français. Gynecol Obstet Fertil Senol. 2023;51(11-12):493-510.
  2. Ovadia C, Seed PT, Sklavounos A, et al. Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses. Lancet. 2019;393(10174):899-909.
  3. Powell AM, Sakuma-Oyama Y, Oyama N, Albert S, Bhogal B, Kaneko F, et al. Usefulness of BP180 NC16a enzyme-linked immunosorbent assay in the serodiagnosis of pemphigoid gestationis and in differentiating between pemphigoid gestationis and pruritic urticarial papules and plaques of pregnancy. Arch Dermatol. 2005;141(6):705-10.
  4. Centre de référence des maladies bulleuses auto-immunes. Protocole national de diagnostic et de soins (PNDS) : Maladies bulleuses auto-immunes, pemphigoïde de la grossesse. Synthèse à destination du médecin traitant (HAS, 2016-2017).
  5. Society for Maternal-Fetal Medicine (SMFM), Lee RH, Greenberg M, Metz TD, Pettker CM. Society for Maternal-Fetal Medicine Consult Series #53: Intrahepatic cholestasis of pregnancy. Am J Obstet Gynecol. 2021;224(2):B2-B9.
  6. Nederlandse Vereniging voor Obstetrie en Gynaecologie (NVOG). Richtlijn Zwangerschapscholestase, module « Zwangerschapscholestase », 6 novembre 2024 (Pays-Bas).
  7. Hagenbeck C, Hamza A, Kehl S, et al. Management of Intrahepatic Cholestasis of Pregnancy: Recommendations of the Working Group on Obstetrics and Prenatal Medicine - Section on Maternal Disorders. Geburtshilfe Frauenheilkd. 2021;81(8):922-939 (Allemagne).
  8. Royal College of Obstetricians and Gynaecologists. Intrahepatic cholestasis of pregnancy. Green-top Guideline No. 43, juin 2022 (Girling J, et al. BJOG. 2022;129(13):e95-e114).
  9. Mitchell AL, Ovadia C, Syngelaki A, et al. Re-evaluating diagnostic thresholds for intrahepatic cholestasis of pregnancy: case-control and cohort study. BJOG. 2021;128(10):1635-1644.
  10. Cwm Taf Morgannwg University Health Board (pays de Galles). Intrahepatic Cholestasis of Pregnancy (ICP) Guideline, version 2, août 2024 (guide hospitalier reprenant le RCOG 2022).
  11. Collège national des gynécologues et obstétriciens français (CNGOF). Post-partum. Recommandations pour la pratique clinique, 2015 (texte court : Sénat MV, et al. J Gynecol Obstet Biol Reprod (Paris). 2015;44(10):1157-66).